The Parkinson disease gene LRRK2: evolutionary and structural insights

Ignacio Marín1

  • 1Departamento de Genética, Universidad de Valencia, Burjassot, Spain. ignacio.marin@uv.es

Insights

The leucine-rich repeat kinase 2 (LRRK2) gene, linked to Parkinson disease (PD), evolved after the protostome-deuterostome split. Its unique repeats suggest caution when using invertebrate models for human LRRK2 research.

Area of Science:

  • Evolutionary biology
  • Genetics
  • Neuroscience

Background:

  • Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a significant cause of familial and sporadic Parkinson disease (PD).
  • LRRK2 is part of the Roco gene family, characterized by Roc (GTPase) and COR (conserved oligomerization region) domains, with LRRK2 also possessing a kinase domain.

Purpose of the Study:

  • To investigate the evolutionary origin and history of the LRRK2 gene and its associated domains.
  • To assess the suitability of invertebrate models for studying human LRRK2 function in Parkinson disease.

Main Methods:

  • Phylogenetic and structural analyses of the COR, Roc, and kinase domains within Roco proteins.
  • Sequence analysis of the Roc GTPase domain.
  • Structural modeling of LRRK2 based on known kinase structures.

Main Results:

  • LRRK2 emerged from a gene duplication event post-protostome-deuterostome split, followed by the acquisition of a novel N-terminal repeat absent in paralogs and protostome LRRK proteins.
  • Phylogenetic analyses indicate that structural similarities between Dictyostelium discoideum and animal LRRK genes are due to independent acquisition of kinase domains, not shared ancestry.
  • The LRRK2 Roc GTPase domain is related to, but distinct from, small GTPases like Rab, Ras, and Rho. PD-associated mutations may affect local protein folding without altering overall structure.

Conclusions:

  • The unique evolutionary trajectory of LRRK2, including its specific repeats, suggests that invertebrate models like Drosophila or Caenorhabditis may not accurately represent human LRRK2 function in Parkinson disease.
  • Structural modeling indicates that Parkinson disease-linked mutations in LRRK2 might disrupt local protein conformation, providing insights into disease mechanisms.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.